From the category archives:

Articles

New Treatment for Peripheral Neuropathy

by chris heimlich on February 14, 2010

Millions of Americans suffer with Peripheral Neuropathy and until recently there was no specific treatment available. Peripheral Neuropathy is often associated with Diabetes, but can occur on its own. Typical treatments in the past included physical therapy, medication and in severe cases even surgery, all of these therapies offer little or no relief. Neurologist, Family Physicians and Podiatrists are now referring their patients for Anodyne Therapy with excellent results.

Anodyne Therapy is the only FDA approved treatment specifically for Peripheral Neuropathy. Anodyne Therapy utilizes the healing power of infrared light to stimulate increased nerve function and blood flow to decrease pain and improve feeling. Anodyne Therapy is completely painless, covered by Medicare and extremely effective. Medical research has shown that patients treated with Anodyne therapy experience the following results:

Significant pain relief : 88% , Increased sensory perception 96%, return to normal sensory perception 60% and an overall 72% increase in daily activity levels. There are no side effects and few contra indications for Anodyne Therapy and because it works on the underlying cause of the problem the results are long lasting.

The symptoms of Peripheral Neuropathy usually effect the feet and calves but can also effect the hands and arms. Peripheral Neuropathy can present itself in a number of different ways including; numbness, pain, loss of feeling, weak muscles, difficulty walking and an odd feeling often described as ” a wet sock squeezing the feet.” These symptoms often effect older patients with diabetes and lead to secondary problems including difficulty with walking, balance and the basic activities of daily living.

“A typical patient receiving Anodyne Therapy will receive 24-30 sessions and start to notice results about half way through their treatment plan. A patient is seen three times a week until the therapy is concluded states Maricel Lazo, PT of Monmouth Advanced Medicine in Freehold. She also stated,” Our patients receive Anodyne Therapy, ultrasound, joint mobilizations and strengthening exercises with our physical therapist to insure their long term success. I have seen patients who have been suffering for 20+ years and those requiring walkers return to near normal function in just a couple on months.” Anodyne Therapy is available in only a hand full of clinics in New Jersey and proper diagnosis is a key to the therapy’s success.

I welcome any comments or questions. Please email me at szodkoy@hotmail.com

Dr. Steven Zodkoy
Chiropractor
Certified Clinical Nutritionist
Certified Nutritional Specialist
Diplomate American Clinical Board of Nutrition

Article Source: http://EzineArticles.com/?expert=Steven_Zodkoy

 

{ 0 comments }

Triglyceride Levels Predict Diabetic Neuropathy Progression

by chris heimlich on February 14, 2010

Diabetic peripheral neuropathy is an abnormality of the nervous system in diabetics which results in a loss of sensation in the feet and the legs. The exact cause of peripheral neuropathy in diabetics is not clearly understood, but many theories exist. One popular theory is based on the loss of small vessel blood flow to the nerves, which impairs the nerves and results in nerve dysfunction. A new study, published online in the journal Diabetes, found that elevated triglycerides were associated with the progression of diabetic neuropathy (1). Researchers at the University of Michigan and Wayne State University evaluated 427 diabetic patients with neuropathy. The sural nerve, which travels on the outside of the leg down to the foot, was used to measure fiber density, the nerve signal speed and vibration threshold. After one year, those individuals with high triglycerides at baseline had significant progression of their neuropathy in comparison to those with normal triglyceride levels at baseline. The duration of diabetes, active treatment of diabetes or body mass index were not associated with neuropathy progression. The authors concluded that triglyceride levels are an active predictor of neuropathy progression in diabetics.

The authors stated that the study findings reinforced the link between cardiovascular disease and peripheral neuropathy. Triglycerides are a type of fat the body uses to store energy. When food consumed exceeds calories exerted, the body stores the excess calories in fat cells as triglycerides. Triglycerides are part of the blood lipid panel used to evaluate cardiovascular disease risk. Elevated triglycerides are a well-known cardiovascular disease risk factor.

The idea that lipids are associated with small blood vessel disease (microangiopathy) is not new. Previous studies have found associations between high levels of triglycerides in the blood and microangiopathy in diabetics (2). The lack of blood flow to the nerves, as a result of microangiopathy, causes changes within the nerves (demyelination and axonal degeneration) and results in nerve dysfunction. Microangiopathy causes the blood vessel lining to thicken which results in a narrowing of the vessel lumen, reducing blood flow (3). Without adequate blood flow, the nerves undergo changes, which ultimately result in nerve dysfunction. This recent research reinforces the link between small blood vessel disease and diabetic peripheral neuropathy.

1. Wiggin TD et al. Elevated Triglycerides Correlate with Progression of Diabetic Neuropathy. Diabetes published online, May 1, 2009, as db08-1771.

2. Eckel RH et al. Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care. 1981 Jul-Aug;4(4):447-53.

3. Powell HC. Microangiopathy in human diabetic neuropathy. Acta Neuropathologica. Volume 68, Number 4 / December, 1985.

Christine Dobrowolski, DPM is a podiatrist and owner of Northcoast footcare, Inc an online resource for foot health information and foot care products. More information on diabetic neuropathy.

Article Source: http://EzineArticles.com/?expert=Christine_Dobrowolski,_DPM

Artilcle written by Christine Dobrowolski, DPM

{ 0 comments }